Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
Massimiliano Cadamuro(University of Padua), Luca Fabris(University of Padua), Luigi Dall’Olmo, Stefano Indraccolo(University of Padua), Mario Strazzabosco(Smilow Cancer Hospital), Marco Massani(Ca' Foncello Hospital), Valeria Mariotti(University of Padua), Giorgia Nardo(Johannes Gutenberg University Mainz), Chiara Milani(University of Milano-Bicocca), Tommaso Stecca(Ca' Foncello Hospital), Anja Moncsek(University Hospital of Zurich), Romina Fiorotto(Yale University), Simone Brivio(University of Milano-Bicocca), Maria Cristina Malerba(University of Milano-Bicocca), Marta Vismara(University of Milano-Bicocca), Joachim C. Mertens(University Hospital of Zurich), Eleonora Milani(University of Padua), Christian D. Fingas(Essen University Hospital), Carlo Spirlı̀(Cancer Research Center)
Cited by 187
Related Papers
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
|Hepatology|2018|340
Abnormal Liver Function Tests in Patients With COVID‐19: Relevance and Potential Pathogenesis
|Hepatology|2020|302
Platelet-Derived Growth Factor-D And Rho Gtpases Regulate Recruitment of Cancer-Associated Fibroblasts in Cholangiocarcinoma
|Hepatology|2013|167